Table 4. Multivariate Cox regression analysis for male breast cancer survival.
| Variable | B | SE | Wald χ2 | P | HR (95% CI) |
|---|---|---|---|---|---|
| T stage | −1.279 | 0.290 | 4.211 | 0.015 | 0.218 (0.072–0.724) |
| TNM stage | −2.338 | 0.439 | 7.345 | 0.016 | 0.102 (0.011–0.420) |
| ER status | −0.120 | 0.915 | 0.224 | 0.764 | 0.823 (0.191–3.123) |
| PR status | 1.885 | 0.763 | 9.347 | 0.001 | 6.558 (2.953–11.800) |
| Chemotherapy | −0.224 | 0.437 | 0.408 | 0.523 | 0.721 (0.328–1.954) |
| Endocrine therapy | 2.658 | 1.215 | 4.382 | 0.040 | 9.960 (1.557–14.260) |
ER, estrogen receptor; PR, progesterone receptor; HR, hazard ratio; CI, confidence interval.